Who Paid My Doc
iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study
Research payments
$431,976
Through program year 2021, $431,976 in research payments was reported against iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study, across 152 payments, paid by Glaukos Corporation.
- Paid by
- Glaukos Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $81,038 | 56 |
| 2020 | Research | $350,938 | 96 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Kent Bashford Fort Collins, CO Named on 8 payments
- Steven Vold Fayetteville, AR Named on 8 payments
- Steven Sarkisian Oklahoma City, OK Named on 7 payments
- George Reiss Glendale, AZ Named on 7 payments
- Joon Kim Morrow, GA Named on 6 payments
- Frank Cotter Roanoke, VA Named on 5 payments
- Steven Day Spokane, WA Named on 5 payments
- Francis Dambrosio Lancaster, MA Named on 5 payments
- Steven Simmons Slingerlands, NY Named on 5 payments
- Michael Stiles Overland Park, KS Named on 5 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.